Sanzyme Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
- Paid Up Capital ₹ 7.68 Cr
- Company Age 55 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 37.00 Cr
- Satisfied Charges ₹ 237.14 Cr
- Revenue Growth 98.20%
- Profit Growth -97.76%
- Ebitda -27.87%
- Net Worth 2.85%
- Total Assets 4.42%
About Sanzyme
Sanzyme Private Limited (SPL) was founded in India on 05 August 1969 and has a glorious history of 55 years and six months. Its registered office is in Hyderabad, Telangana, India.
The Corporate was formerly known as Uni-Sankyo Ltd. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 7.68 Cr.
The company currently has active open charges totaling ₹37.00 Cr. The company has closed loans amounting to ₹237.14 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Sanzyme Private Limited India are Sumit Jamad as CFO and Kona Murthy as Company Secretary. Subrahmanyaprasad Kompella, Dhruv Soman, Raunak Soman, and Three other members serve as directors at the Company.
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24235TG1969PTC001282
- Company No.
001282
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Aug 1969
- Date of AGM
19 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
What products or services does Sanzyme Private Limited offer?
Sanzyme Private Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements, Sexual Wellness Products, Fertility Enhancer, Bird Food, Poultry & Animal Food, Fish Foods, Digestive System Drugs & Medicines, Pre & Probiotic Capsule, Probiotic And Prebiotic Drugs, Multi-strain Probiotic.
Who are the key members and board of directors at Sanzyme?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sumit Jamad  | CFO | 24-Dec-2018 | Current |
| Kona Murthy | Company Secretary | 09-May-1996 | Current |
| Jay Soman | Managing Director | 01-Jun-2010 | Current |
Board Members (5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Raunak Soman | Director | 28-Sep-2021 | Current |
| Subrahmanyaprasad Kompella | Whole-Time Director | 27-Oct-2017 | Current |
| Dhruv Soman | Director | 11-Jun-2020 | Current |
| Surapaneni Rao | Director | 19-Aug-1992 | Current |
| Arun Akinepally | Director | 16-Mar-2012 | Current |
Financial Performance of Sanzyme.
Sanzyme Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 98.2% increase. The company also saw a substantial fall in profitability, with a 97.76% decrease in profit. The company's net worth moved up by a moderate rise of 2.85%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanzyme?
In 2023, Sanzyme had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Suraj Laboratories Private LimitedSurapaneni Rao is a mutual person
Espi Industries And Chemicals Pvt LtdArun Akinepally is a mutual person
Andhra Chamber Of CommerceSurapaneni Rao is a mutual person
Sanzyme Biologics Private LimitedDhruv Soman, Raunak Soman and 2 more are mutual person
Plantus Private LimitedSubrahmanyaprasad Kompella and Jay Soman are mutual person
Charges (Loans)
₹37.00 Cr
₹237.14 Cr
Charges Breakdown by Lending Institutions
- Others : 37.00 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Nov 2016 | Others | ₹37.00 Cr | Open |
| 28 Nov 2016 | Others | ₹46.54 Cr | Satisfied |
| 15 Sep 2014 | Citi Bank N.A. | ₹10.00 Cr | Satisfied |
| 21 Mar 2013 | Technology Development Board | ₹5.00 Cr | Satisfied |
| 13 Mar 2013 | Citi Bank N.A. | ₹8.00 Cr | Satisfied |
How Many Employees Work at Sanzyme?
Sanzyme has a workforce of 193 employees as of Sep 11, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanzyme, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanzyme's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
